๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mortality in Parkinson's disease and its association with dementia and depression

โœ Scribed by T. A. Hughes; H. F. Ross; R. H. S. Mindham; E. G. S. Spokes


Book ID
109337081
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
111 KB
Volume
110
Category
Article
ISSN
0001-6314

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Subthreshold depression in patients with
โœ Uwe Ehrt; Kolbjรธrn Brรธnnick; Peter Paul De Deyn; Murat Emre; Sibel Tekin; Roger ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 95 KB ๐Ÿ‘ 1 views

## Abstract ## Background About 40% of the patients with Parkinson's disease (PD) have depressive symptoms, either major depression (MD) or subthreshold depression. Depression was found to be associated with age and age at onset of PD, female gender, more severe parkinsonism, in particular with le

Current treatment of dementia with Lewy
โœ David J. Burn; Ian G. McKeith ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB

Dementia in Parkinson's disease (PDD) is a frequent and distressing complication with major consequences. Clinical and pathological features closely link PDD and dementia with Lewy bodies (DLB), suggesting they represent part of the same disease spectrum. Although dopaminergic deficiency primarily d

Visual symptoms in Parkinson's disease a
โœ Neil K. Archibald; Mike P. Clarke; Urs P. Mosimann; David J. Burn ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 132 KB

## Abstract Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cogni

Cholinergic and other neurotransmitter m
โœ Paul T. Francis; Elaine K. Perry ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB

It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b